From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA opens new path for Alzheimer's treatments

from Bloomberg

U.S. drug regulators wants to let drugmakers test Alzheimer’s disease treatments on patients years before the disease shows outward signs, and could approve the therapies based on subtle biological signals rather than proof they alleviate symptoms. The Food and Drug Administration proposal will open new paths for drugmakers after repeated failures from companies including Pfizer Inc., Eli Lilly & Co. and Merck & Co. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063